Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Of A Fetal Sex Determination Test At 36-56 Days Gestation In Assisted Reproductive Technology (ART) Achieved Pregnancies

NCT01021085 is registered in ClinicalTrials.gov with Sequenom, Inc. as lead sponsor.

NCT NCT01021085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01021085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Of A Fetal Sex Determination Test At 36-56 Days Gestation In Assisted Reproductive Technology (ART) Achieved Pregnancies
Lead sponsor
Sequenom, Inc.
Phase
Observational
Overall status
Completed
Start date
April 30, 2009
Completion date
September 30, 2011
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

fetal sex determination